Literature DB >> 7902216

Removal of beta III isotype enhances taxol induced microtubule assembly.

Q Lu1, R F Luduena.   

Abstract

The interaction of beta III-depleted tubulin with taxol was investigated. A monoclonal antibody against the beta III tubulin isotype was immobilized on a sepharose 4B column and used to remove the beta III tubulin isotype from unfractionated tubulin. The assembly of beta III-depleted tubulin in the presence of taxol was enhanced compared to unfractionated tubulin. The critical concentration of unfractionated tubulin in the presence of 10 microM taxol is 0.4 mg/ml, while the critical concentration of beta III-depleted tubulin is 0.16 mg/ml. At different concentration of taxol, the assembly of beta III-depleted tubulin is increased relative to that of unfractionated tubulin and reaches the maximum at about a 1:1 ratio of tubulin and taxol. The assembly of unfractionated tubulin and beta III-depleted tubulin has also been studied by electron microscopy. After 2 minutes at 37 degrees C, unfractionated tubulin assembly in the presence of 10 microM taxol results only in ribbon-like and ring structures; there are no visible microtubules. By 5 minutes, microtubules appear and increase in length. The assembly of beta III-depleted tubulin in the presence of 10 microM taxol occurs more quickly. In contrast to the case with unfractionated tubulin, beta III-depleted tubulin assembles within 2 minutes into microtubules which increase in length with time. At 30 minutes, microtubules assembled from beta III-depleted tubulin are shorter than the microtubules assembled from unfractionated tubulin. There is no visible difference between the microtubules assembled from unfractionated tubulin and beta III-depleted tubulin. Taxol-induced beta III-depleted tubulin assembly is more resistant to the inhibiting effect of podophyllotoxin and colchicine. It is also less sensitive to the inhibiting effect of cold temperature.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902216     DOI: 10.1247/csf.18.173

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  29 in total

1.  Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Authors:  M Kavallaris; D Y Kuo; C A Burkhart; D L Regl; M D Norris; M Haber; S B Horwitz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

Review 3.  Drug discovery targeting cell division proteins, microtubules and FtsZ.

Authors:  Iwao Ojima; Kunal Kumar; Divya Awasthi; Jacob G Vineberg
Journal:  Bioorg Med Chem       Date:  2014-03-05       Impact factor: 3.641

Review 4.  Polarity regulation in migrating neurons in the cortex.

Authors:  Orly Reiner; Tamar Sapir
Journal:  Mol Neurobiol       Date:  2009-03-28       Impact factor: 5.590

5.  Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy.

Authors:  Guillaume Ploussard; Stéphane Terry; Pascale Maillé; Yves Allory; Nanor Sirab; Laurence Kheuang; Pascale Soyeux; Nathalie Nicolaiew; Estelle Coppolani; Bernard Paule; Laurent Salomon; Stéphane Culine; Ralph Buttyan; Francis Vacherot; Alexandre de la Taille
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

6.  Expression of excision repair cross-complementation group 1 and class III β-tubulin in thymic carcinoma.

Authors:  Katsuhiro Okuda; Risa Oda; Ayumi Suzuki; Tsutomu Tatematsu; Hiroshi Haneda; Satoru Moriyama; Motoki Yano; Ryoichi Nakanishi
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

7.  Expression of ERCC1 and class III β-tubulin is associated with the survival of resected stage III non-small cell lung cancer patients treated with induction chemoradiotherapy using carboplatin-taxane.

Authors:  Cheng-Long Huang; Kyuichi Kadota; Dage Liu; Masaki Ueno; Nariyasu Nakasima; Shinya Ishikawa; Masashi Gotoh; Noriyuki Misaki; Sung-Soo Chang; Hiroyasu Yokomise
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

8.  Neurogenesis and neurite outgrowth in the spinal cord of chicken embryos and in primary cultures of spinal neurons following knockdown of Class III beta tubulin with antisense morpholinos.

Authors:  Richard P Tucker; Ha Tran; Qizhi Gong
Journal:  Protoplasma       Date:  2008-09-30       Impact factor: 3.356

9.  Increased expression of class III beta-tubulin in castration-resistant human prostate cancer.

Authors:  S Terry; G Ploussard; Y Allory; N Nicolaiew; F Boissière-Michot; P Maillé; L Kheuang; E Coppolani; A Ali; F Bibeau; S Culine; R Buttyan; A de la Taille; F Vacherot
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

10.  Management of advanced breast cancer with the epothilone B analog, ixabepilone.

Authors:  William Gradishar
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.